Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Reata, A Wholly Owned Subsidiary Of Biogen

Clinical trials sponsored by Reata, A Wholly Owned Subsidiary Of Biogen, explained in plain language.

Drug trial aims to ease debilitating diabetic nerve pain

Symptom relief Terminated

This study tested an investigational drug called RTA 901 to see if it was safe and could reduce pain in people with diabetic peripheral neuropathic pain (DPNP). About 209 participants with diabetes and significant nerve pain in their feet and legs were randomly assigned to receiv…

Phase: PHASE2 • Sponsor: Reata, a wholly owned subsidiary of Biogen • Aim: Symptom relief

Last updated Mar 27, 2026 12:38 UTC